MassMutual Private Wealth & Trust’s Procept Biorobotics PRCT Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.03K	Sell	90 -210	-70%	-$5.26K	﹤0.01%	2004
2026 Q1	$7.5K	Buy	+300	New	+$8.45K	﹤0.01%	1503
2025 Q2	–	Sell	-30	Closed	-$1.75K	–	2466
2025 Q1	$1.75K	Sell	30 -73	-71%	-$4.98K	﹤0.01%	1957
2024 Q4	$8.29K	Buy	+103	New	+$8.8K	﹤0.01%	1330
2023 Q4	–	Sell	-19	Closed	-$623	–	2059
2023 Q3	$623	Buy	19 +11	+138%	+$375	﹤0.01%	1776
2023 Q2	$283	Buy	+8	New	+$265	﹤0.01%	1848

Other funds holding PRCT

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

WRPWM

Werba Rubin Papier Wealth Management San Jose, California $824M AUM 24.76% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

FRA

Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return

MassMutual Private Wealth & Trust's PRCT Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Procept Biorobotics (PRCT) stake by 70% in Q2 2026, selling an estimated $5.26K and leaving 90 shares worth $2.03K. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

MassMutual Private Wealth & Trust first reported a position in PRCT in Q2 2023 and has held it in 6 quarters since. The position peaked at $8.29K in Q4 2024. 67 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

MassMutual Private Wealth & Trust held 90 shares of Procept Biorobotics worth $2.03K as of Q2 2026.
MassMutual Private Wealth & Trust sold 210 Procept Biorobotics shares in Q2 2026, an estimated $5.26K.
Procept Biorobotics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2004 holding.
MassMutual Private Wealth & Trust first reported a position in Procept Biorobotics in Q2 2023 and has held it in 6 quarters since.
MassMutual Private Wealth & Trust's Procept Biorobotics position peaked at $8.29K in Q4 2024.
67 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.